Acciones InDex Pharmaceuticals Holding AB (publ) Nasdaq Stockholm
Acciones
SE0008966295
Farmacéuticos
Ventas 2024 * | - | Ventas 2025 * | - | Capitalización | 270 M 2874,29 M 249 M |
---|---|---|---|---|---|
Resultado Neto 2024 * | -259 M -2761,9 M -239 M | Resultado Neto 2025 * | -221 M -2356,68 M -204 M | VE / Ventas 2024 * | - |
Deuda neta 2024 * | 86,32 M 920 M 79,59 M | Deuda neta 2025 * | 306 M 3261,49 M 282 M | VE / Ventas 2025 * | - |
P/E ratio 2024 * |
-1,03
x | P/E ratio 2025 * |
-1,23
x | Empleados | - |
Rendimiento 2024 * |
-
| Rendimiento 2025 * |
-
| Flotante | 62,47 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jenny Sundqvist
CEO | Chief Executive Officer | 53 | 01/01/23 |
Johan Gileus
DFI | Director of Finance/CFO | 59 | 01/05/17 |
Charlotte Admyre
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Uli Alf Hacksell
BRD | Director/Board Member | 74 | 01/01/16 |
Director/Board Member | 68 | 01/01/11 | |
Chairman | 72 | 01/01/11 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+38,51 % | 727 mil M | |
+33,05 % | 599 mil M | |
-6,23 % | 354 mil M | |
+18,78 % | 328 mil M | |
+1,35 % | 277 mil M | |
+16,00 % | 243 mil M | |
+8,09 % | 205 mil M | |
-5,77 % | 203 mil M | |
+6,19 % | 164 mil M |